We need you! Join our contributor community and become a WikEM editor through our open and transparent promotion process.
Paromomycin
From WikEM
Contents
Administration
- Type: Amebicide
- Dosage Forms: 250
- Routes of Administration: Oral
- Common Trade Names: Humatin
Adult Dosing
Intestinal amebiasis
- 25-35mg/kg/day PO divided tid x5-10 days
- Give with food
Hepatic encephalopathy
- adjunct treatment: 1000mg PO qid x5-6 days
- Give with food
Pediatric Dosing
Intestinal amebiasis
- 25-35mg/kg/day PO divided tid x5-10 days
Special Populations
- Poorly absorbed when given orally
- Use during pregnancy has limited data
Renal Dosing
- No change in dosing
Hepatic Dosing
- No change in dosing
Contraindications
- Allergy to class/drug
- GI obstruction
- caution if ulcerative colitis
- caution if inflammatory bowel disease
- caution if renal impairment
Adverse Reactions
Serious
- nephrotoxicity
- ototoxicity, auditory
- ototoxicity, vestibular
- neurotoxicity
- neuromuscular blockade
- malabsorption syndrome (prolonged use)
- superinfection (prolonged use)
- enterocolitis
Common
Pharmacology
- Half-life: Unknown
- Metabolism: CYP450
- Excretion: Feces
Mechanism of Action
Bactericidal and amebicidal. Paromomycin binds to bacterial 30S ribosomal subunit, inhibiting protein synthesis; it suppresses urease producing bacteria, reducing ammonia absorption from gut
Comments
See Also
References
UpToDate, Epocrates
Authors
Kristina Shigyo, Ross Donaldson, Neil Young, Daniel Ostermayer, Claire